Skip to main content
Erschienen in: Journal of Immigrant and Minority Health 4/2013

01.08.2013 | Original Paper

Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy

verfasst von: Fabio Tramuto, Carmelo M. Maida, Giuseppina M. E. Colomba, Paola Di Carlo, Giovanni Mazzola, Valentina Li Vecchi, Mario Affronti, Giuseppe Montalto, Francesco Vitale

Erschienen in: Journal of Immigrant and Minority Health | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

In Italy, about 7 % of the resident population is represented by immigrants originating from geographic regions at high endemicity for hepatitis B virus infection. This study aims to assess the prevalence of occult HBV infection (OBI) including the identification of HBV-genotypes in a population of immigrants serologically negative for hepatitis B surface antigen (HBsAg). Between May 2006 and May 2010, 339 immigrants were tested for markers of HBV, hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. HBV-DNA was tested by using nested-PCR assays on three different genetic region. HBV-DNA was detected in plasma samples of 11/339 (3.2 %) patients. Most of them had no serological markers of HBV infection, 3/58 (5.2 %) were anti-HBc-alone, and 4/13 (30.8 %) were anti-HIV positive. HIV positivity was the only factor independently associated with the higher probability of observing OBI (OR = 16.5, p < 0.001). No HCV co-infected patients were found. Genotype D was detected in 9/11 (81.8 %) OBI cases, while the remaining two (18.2 %) were classified as genotype E. Although OBI was found at lower rate than expected among immigrants from highly endemic countries, anti-HBc alone positivity was confirmed as a sentinel marker of occult HBV infection. Nevertheless, a marked heterogeneity of HBV markers was found among HBV-DNA positive subjects. Our finding evidenced the predominance of HBV-genotype D viral strains among OBI cases, also in those from geographical areas where overt HBV infections are mainly sustained by viral genotypes other than D.
Literatur
1.
Zurück zum Zitat Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010;58:254–7.CrossRef Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010;58:254–7.CrossRef
2.
Zurück zum Zitat Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102–10.CrossRefPubMed Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102–10.CrossRefPubMed
3.
Zurück zum Zitat Pollicino T, Saitta C, Raimondo G. Hepatocellular carcinoma: the point of view of the hepatitis B virus. Carcinogenesis. 2011;32:1122–32.CrossRefPubMed Pollicino T, Saitta C, Raimondo G. Hepatocellular carcinoma: the point of view of the hepatitis B virus. Carcinogenesis. 2011;32:1122–32.CrossRefPubMed
4.
Zurück zum Zitat Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P. Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D’Arminio Monforte A; HepaICONA and the ICONA Study Groups. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection. 2009;37:445–9.CrossRefPubMed Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P. Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D’Arminio Monforte A; HepaICONA and the ICONA Study Groups. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection. 2009;37:445–9.CrossRefPubMed
5.
Zurück zum Zitat Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G. ANRS CO8 APROCO-COPILOTE Study Group. Occult hepatitis B in HIV-HCV coinfected patients. Scand J Infect Dis. 2008;40:835–9.CrossRefPubMed Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G. ANRS CO8 APROCO-COPILOTE Study Group. Occult hepatitis B in HIV-HCV coinfected patients. Scand J Infect Dis. 2008;40:835–9.CrossRefPubMed
6.
Zurück zum Zitat Song EY, Yun YM, Park MH, Seo DH. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology. 2009;52:57–62.CrossRefPubMed Song EY, Yun YM, Park MH, Seo DH. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology. 2009;52:57–62.CrossRefPubMed
7.
Zurück zum Zitat Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N. Can the Serological Status of “Anti-HBc Alone” Be Considered a Sentinel Marker for Detection of ‘‘Occult’’ HBV Infection? J Med Virol. 2008;80:577–82.CrossRefPubMed Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N. Can the Serological Status of “Anti-HBc Alone” Be Considered a Sentinel Marker for Detection of ‘‘Occult’’ HBV Infection? J Med Virol. 2008;80:577–82.CrossRefPubMed
8.
Zurück zum Zitat Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48:743–6.CrossRefPubMed Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48:743–6.CrossRefPubMed
9.
Zurück zum Zitat Raffa G, Maimone S, Cargnel A, Santantonio T, Antonucci G, Massari M, Schiavini M, Caccamo G, Pollicino T, Raimondo G. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. AIDS. 2007;21:2171–5.CrossRefPubMed Raffa G, Maimone S, Cargnel A, Santantonio T, Antonucci G, Massari M, Schiavini M, Caccamo G, Pollicino T, Raimondo G. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. AIDS. 2007;21:2171–5.CrossRefPubMed
10.
Zurück zum Zitat Caritas/Migrantes. Dossier Statistico–XIX Rapporto sull’immigrazione. Rome: IDOS, 2009. Caritas/Migrantes. Dossier Statistico–XIX Rapporto sull’immigrazione. Rome: IDOS, 2009.
11.
Zurück zum Zitat Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19–26.CrossRefPubMed Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19–26.CrossRefPubMed
12.
Zurück zum Zitat Chan HL, Wong GL, Tse CH, Chim AM, Yiu KK, Chan HY, Sung JJ, Wong VW. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin Gastroenterol Hepatol. 2009;7:1361–6.CrossRefPubMed Chan HL, Wong GL, Tse CH, Chim AM, Yiu KK, Chan HY, Sung JJ, Wong VW. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin Gastroenterol Hepatol. 2009;7:1361–6.CrossRefPubMed
13.
Zurück zum Zitat McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3:334–42.CrossRefPubMed McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3:334–42.CrossRefPubMed
14.
Zurück zum Zitat Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology. 2003;46:329–38.CrossRefPubMed Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology. 2003;46:329–38.CrossRefPubMed
15.
Zurück zum Zitat Scotto G, Martinelli D, Di Tullio R, Fazio V. Epidemiological and clinical features of hepatitis B virus genotypes among immigrants in Southern Italy. Hepat Res Treat. 2010;2010:878356.PubMed Scotto G, Martinelli D, Di Tullio R, Fazio V. Epidemiological and clinical features of hepatitis B virus genotypes among immigrants in Southern Italy. Hepat Res Treat. 2010;2010:878356.PubMed
16.
Zurück zum Zitat El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, Chiba T, Hosney AM. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J Gastroenterol. 2009;44:359–64.CrossRefPubMed El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, Chiba T, Hosney AM. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J Gastroenterol. 2009;44:359–64.CrossRefPubMed
17.
Zurück zum Zitat Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010;4:658–61.PubMed Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010;4:658–61.PubMed
18.
Zurück zum Zitat Kang SY, Kim MH, Lee WI. The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea. J Med Virol. 2010;82:1508–14.CrossRefPubMed Kang SY, Kim MH, Lee WI. The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea. J Med Virol. 2010;82:1508–14.CrossRefPubMed
19.
Zurück zum Zitat Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23–9.CrossRefPubMed Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23–9.CrossRefPubMed
20.
Zurück zum Zitat Gibney KB, Torresi J, Lemoh C, Biggs BA. Isolated core antibody hepatitis B in sub-Saharan African immigrants. J Med Virol. 2008;80:1565–9.CrossRefPubMed Gibney KB, Torresi J, Lemoh C, Biggs BA. Isolated core antibody hepatitis B in sub-Saharan African immigrants. J Med Virol. 2008;80:1565–9.CrossRefPubMed
21.
Zurück zum Zitat Greub G, Frei PC. Presence of low levels of anti-HBs antibody in so-called ‘anti-HBc alone’ subjects. Liver. 2001;21:380–3.CrossRefPubMed Greub G, Frei PC. Presence of low levels of anti-HBs antibody in so-called ‘anti-HBc alone’ subjects. Liver. 2001;21:380–3.CrossRefPubMed
22.
Zurück zum Zitat European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol. 2009;50:227–42.CrossRef European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol. 2009;50:227–42.CrossRef
23.
Zurück zum Zitat Bihl F, Alaei M, Negro F. The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians. Swiss Med Wkly. 2010;140:154–9.PubMed Bihl F, Alaei M, Negro F. The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians. Swiss Med Wkly. 2010;140:154–9.PubMed
24.
Zurück zum Zitat Fujise K, Tatsuzawa K, Kono M, Hoshina S, Tsubota A, Niiya M, Namiki Y, Tada N, Tajiri H. A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis. World J Hepatol. 2011;3:56–60.CrossRefPubMed Fujise K, Tatsuzawa K, Kono M, Hoshina S, Tsubota A, Niiya M, Namiki Y, Tada N, Tajiri H. A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis. World J Hepatol. 2011;3:56–60.CrossRefPubMed
25.
Zurück zum Zitat Chen CH, Changchien CS, Lee CM, Tung WC, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer. 2009;125:621–9.CrossRefPubMed Chen CH, Changchien CS, Lee CM, Tung WC, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer. 2009;125:621–9.CrossRefPubMed
26.
Zurück zum Zitat Yildirim M, Yavuz MT, Ozdemir D, Behçet M, Sencan I. High rate of hepatitis B virus DNA positivity in anti-HBc only-positive patients. Mikrobiyol Bul. 2008;42:535–6.PubMed Yildirim M, Yavuz MT, Ozdemir D, Behçet M, Sencan I. High rate of hepatitis B virus DNA positivity in anti-HBc only-positive patients. Mikrobiyol Bul. 2008;42:535–6.PubMed
27.
Zurück zum Zitat Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol. 2009;81:441–5.CrossRefPubMed Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol. 2009;81:441–5.CrossRefPubMed
28.
Zurück zum Zitat Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F. Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: aquitaine cohort 2002–2003. Clin Infect Dis. 2005;40:750–3.CrossRefPubMed Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F. Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: aquitaine cohort 2002–2003. Clin Infect Dis. 2005;40:750–3.CrossRefPubMed
29.
Zurück zum Zitat Lo Re V III, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:315–20.CrossRefPubMed Lo Re V III, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:315–20.CrossRefPubMed
30.
Zurück zum Zitat Bagaglio S, Bianchi G, Danise A, Porrino L, Uberti-Foppa C, Lazzarin A, Castagna A, Morsica G. Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption. Infection. 2011;39:121–6.CrossRefPubMed Bagaglio S, Bianchi G, Danise A, Porrino L, Uberti-Foppa C, Lazzarin A, Castagna A, Morsica G. Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption. Infection. 2011;39:121–6.CrossRefPubMed
31.
Zurück zum Zitat N’Dri-Yoman T, Anglaret X, Messou E, Attia A, Polneau S, Toni T, Chenal H, Seyler C, Gabillard D, Wakasugi N, Eholié S, Danel C. Occult HBV infection in untreated HIV-infected adults in Côte d’Ivoire. Antivir Ther. 2010;15:1029–34.CrossRefPubMed N’Dri-Yoman T, Anglaret X, Messou E, Attia A, Polneau S, Toni T, Chenal H, Seyler C, Gabillard D, Wakasugi N, Eholié S, Danel C. Occult HBV infection in untreated HIV-infected adults in Côte d’Ivoire. Antivir Ther. 2010;15:1029–34.CrossRefPubMed
32.
Zurück zum Zitat Ratto-Kim S, Garner RP, Kim JH, Jagodzinski LL, Michael NL, Paris R, Redfield RR, Birx DL. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort. J Infect Dis. 2004;189:1988–95.CrossRefPubMed Ratto-Kim S, Garner RP, Kim JH, Jagodzinski LL, Michael NL, Paris R, Redfield RR, Birx DL. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort. J Infect Dis. 2004;189:1988–95.CrossRefPubMed
33.
Zurück zum Zitat Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol. 2011;83:929–34.CrossRefPubMed Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol. 2011;83:929–34.CrossRefPubMed
34.
Zurück zum Zitat Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS. 2006;20:1253–60.CrossRefPubMed Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS. 2006;20:1253–60.CrossRefPubMed
35.
Zurück zum Zitat Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A. Molecular characterisation of occult hepatitis B cases in Greek blood donors. J Med Virol. 2009;81:815–25.CrossRefPubMed Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A. Molecular characterisation of occult hepatitis B cases in Greek blood donors. J Med Virol. 2009;81:815–25.CrossRefPubMed
36.
Zurück zum Zitat Pinarbasi B, Onel D, Cosan F, Akyuz F, Dirlik N, Cakaloglu Y, Badur S, Besisik F, Demir K, Okten A, Kaymakoglu S. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Liver Int. 2009;29:227–30.CrossRefPubMed Pinarbasi B, Onel D, Cosan F, Akyuz F, Dirlik N, Cakaloglu Y, Badur S, Besisik F, Demir K, Okten A, Kaymakoglu S. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Liver Int. 2009;29:227–30.CrossRefPubMed
37.
Zurück zum Zitat Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Salehi M, Ahmadabadi BN, Kennedy D. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection. Clin Res Hepatol Gastroenterol. 2011;35:554–9.CrossRefPubMed Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Salehi M, Ahmadabadi BN, Kennedy D. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection. Clin Res Hepatol Gastroenterol. 2011;35:554–9.CrossRefPubMed
38.
Zurück zum Zitat Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14:1–21.CrossRefPubMed Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14:1–21.CrossRefPubMed
39.
Zurück zum Zitat Weinberger KM, Bauer T, Böhm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol. 2000;81:1165–74.PubMed Weinberger KM, Bauer T, Böhm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol. 2000;81:1165–74.PubMed
40.
Zurück zum Zitat Bahn A, Gerner P, Martiné U, Bortolotti F, Wirth S. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. J Hepatol. 1997;27:973–8.CrossRefPubMed Bahn A, Gerner P, Martiné U, Bortolotti F, Wirth S. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. J Hepatol. 1997;27:973–8.CrossRefPubMed
41.
Zurück zum Zitat Gerner PR, Friedt M, Oettinger R, Lausch E, Wirth S. The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of pre-S2-defective particles in chronically infected children. Virology. 1998;245:163–72.CrossRefPubMed Gerner PR, Friedt M, Oettinger R, Lausch E, Wirth S. The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of pre-S2-defective particles in chronically infected children. Virology. 1998;245:163–72.CrossRefPubMed
42.
Zurück zum Zitat Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology. 1999;29:1252–8.CrossRefPubMed Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology. 1999;29:1252–8.CrossRefPubMed
43.
Zurück zum Zitat Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997;4:11–20.CrossRefPubMed Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997;4:11–20.CrossRefPubMed
Metadaten
Titel
Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy
verfasst von
Fabio Tramuto
Carmelo M. Maida
Giuseppina M. E. Colomba
Paola Di Carlo
Giovanni Mazzola
Valentina Li Vecchi
Mario Affronti
Giuseppe Montalto
Francesco Vitale
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Journal of Immigrant and Minority Health / Ausgabe 4/2013
Print ISSN: 1557-1912
Elektronische ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-012-9699-y

Weitere Artikel der Ausgabe 4/2013

Journal of Immigrant and Minority Health 4/2013 Zur Ausgabe